TWA
ATNM icon

TCI Wealth Advisors’s Actinium Pharmaceuticals ATNM Stock Holding History

TCI Wealth Advisors’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-100
Closed -$945 – 367
2023
Q1 		$945 Hold
100
– – ﹤0.01% 2115
2022
Q4 		$1.06K Hold
100
– – ﹤0.01% 2105
2022
Q3 		$1K Hold
100
– – ﹤0.01% 2032
2022
Q2 		$0 Hold
100
– – ﹤0.01% 2270
2022
Q1 		$1K Hold
100
– – ﹤0.01% 2064
2021
Q4 		$1K Hold
100
– – ﹤0.01% 2154
2021
Q3 		$1K Hold
100
– – ﹤0.01% 2226
2021
Q2 		$1K Hold
100
– – ﹤0.01% 2174
2021
Q1 		$1K Sell
100
-100
-50% -$849 ﹤0.01% 2026
2020
Q4 		$2K Buy
200
+100
+100% +$1.09K ﹤0.01% 1188
2020
Q3 		$1K Hold
100
– – ﹤0.01% 1266
2020
Q2 		$1K Buy
100
+33
+49% +$250 ﹤0.01% 1203
2020
Q1 		$0 Buy
+67
New +$476 ﹤0.01% 1467

Other funds holding ATNM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

TCI Wealth Advisors's ATNM Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Actinium Pharmaceuticals (ATNM) in Q2 2023, closing a stake of 100 shares — an estimated $945 sold.

TCI Wealth Advisors first reported a position in ATNM in Q1 2020 and held it in 13 quarters. The position peaked at $2K in Q4 2020. 71 funds tracked by Wall St. Rank hold ATNM as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Actinium Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 100 Actinium Pharmaceuticals shares in Q2 2023, an estimated $945.
  • TCI Wealth Advisors first reported a position in Actinium Pharmaceuticals in Q1 2020 and held it in 13 quarters.
  • TCI Wealth Advisors's Actinium Pharmaceuticals position peaked at $2K in Q4 2020.
  • 71 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.